NCT00572156 - rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency | Biotech Hunter

Enrollment

106

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

March 31, 2012

Conditions

Insulin-like Growth Factor-1 Deficiency

Interventions

DRUG

NutropinAq® (Somatropin [rDNA origin])

rhGH (Somatropin) 45µg/kg once daily injection

DRUG

Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])

rhGH 45µg/kg and rhIGF-1 150µg/kg once daily injection

DRUG

Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])

rhGH (Somatropin) 45µg/kg and rhIGF-1 (Mecasermin) 50µg/kg once daily injections

DRUG

Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])

rhGH 45µg/kg and rhIGF-1 100µg/kg once daily injections

Trial Locations (1)

Ipsen, Brisbane